Cargando…
Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?
Treatment for advanced prostate cancer has and will continue to grow increasingly complex, owing to the introduction of multiple new therapeutic approaches with the potential to substantially improve outcomes for this disease. Agents that modulate the patient's immune system to fight prostate c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639663/ https://www.ncbi.nlm.nih.gov/pubmed/23634292 http://dx.doi.org/10.1002/cam4.64 |